Breast imaging artificial intelligence tools have shown limited practical impact on patient outcomes, according to new survey data reported by Radiology Business. While these AI tools have enhanced specific elements of breast cancer screening workflows, overall meaningful benefits remain sparse.
Radiologists report that despite incremental improvements in screening processes, the technology has not yet successfully translated into measurably improved clinical outcomes. The findings underscore ongoing questions regarding the direct patient value of current breast imaging AI applications.